On this website we use technical cookies and, subject to your prior consent, third party profiling cookies in order to propose to you advertising and services in line with your preferences. For additional information please visit our cookies policy page. Clicking on “Continue” or browsing this website you will consent to the use of such cookies.   


Diocle S.p.A. will issue, in one or more tranches, senior secured floating rate notes due 2026 in an aggregate principal amount of euro 470,000,000 as part of the financing for the acquisition of 100% of the quota capital of DOC Generici S.r.l..

Financial Details

12/31/19 12/31/18
Total Sales 233,249,000.00 206,317,742.00
Ebitda 93,420,380.00 81,312,791.00
Ebitda Margin +40.00% +39.00%
Ebit 17,164,852.00 16,287,480.00
Ebit Margin +7.00% +8.00%
Result Before Taxes -9,650,291.00 2,190,625.00
Net Result -17,518,726.00 -16,569,522.00
Net Financial Debt / (Cash) -19,811,924.00 223,240,860.00
Net Equity 580,398,444.00 254,487,111.00
Notes 12/31/19  Key Figures from Consolidated Financial Report of Doc Generici S.r.l.

12/31/18  Key Figures from Consolidated Financial Report of Doc Generici S.r.l.  

Listed Instruments


Issuer Profile

Legal Address Via Montenapoleone, 29
ZIP Town 20121
Town, Country Milano (MI), Italia
Internet Website Please visit the relevant issuer/guarantor page
Rating Moody's: B2 / Standard & Poor's: B
Equity Market N/A
ELITE Program N

Investor Relation

Balance Sheets
Price Sensitive Information
Please visit the relevant issuer/guarantor page

The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.